A message to our patients, customers, and valued Trulieve community:

At Trulieve, we are focused on fostering a community of trust and transparency with our patients, employees, and investors. This includes sharing news about everything from our expanding line of high-quality cannabis products to company updates.

This past December you may have seen the allegations by GRIZZLY RESEARCH LLC (“Grizzly”) against Trulieve. These allegations are categorically untrue and we believe were produced for the authors benefit. You can read more about this fraudulent report and our response here

It was clear that Grizzly’s report reflected the opinions of an acknowledged short seller.  We at Trulieve believe in honesty and justice in all facets of business and as such, have launched a lawsuit against Grizzly. In doing so, we are not only protecting our brand, employees, and Trulievers from the damage caused by such false allegations, but hopefully discouraging future reports from unfairly and dishonestly mischaracterizing other companies in our industry.

You can read more about our lawsuit against Grizzly here. If you have any questions or concerns, please feel free to email our investor relations team at IR@trulieve.com

Trulieve has many exciting opportunities on the horizon and we can’t wait to share them with you.  We are here for you because, as we say at Trulieve, we grow one patient and customer at a time.